Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Status:
Terminated
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if hospitalized patients with symptomatic
hyponatremia treated with tolvaptan are in the hospital for less time than patients treated
with fluid restriction. The study will also test if tolvaptan is better than fluid
restriction in treating the symptoms of hyponatremia in hospitalized patients.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.